Member Info for Investor81

Competition Title: Technology Strategy Board CR&D Competition
Project Title: Novel Use of Aptamers and UV Area Imaging for Disease Detection
Lead Organisation: Paraytec
Total Grant Awarded: £149,632

This project brings together the innovative detection technology of Paraytec Ltd with the target recognition technology provided by Aptamer Diagnostic Ltd to create the next generation of detection instruments. These novel platforms will allow rapid field and point-of-care diagnosis based on multiplex detection of markers of disease or contamination. Simultaneous detection of multiple markers will reduce the ambiguity associated with diagnostic systems which look for single markers. It will also save both time and expense associated with routine laboratory based sample screening, allowing them to focus on samples where more detailed analysis is required.

https://www.aptamergroup.co.uk/find-out-more/partnerships/

One last link. Can anyone copy and paste the table?

https://www.aptamergroup.co.uk/aptamers-based-elisa-for-virus-detection-covid-19/

we can employ aptamers in the fight against COVID-19.

Aptamers are commonly referred to as chemical antibodies; however, aptamers are quicker to develop and inexpensive to synthesize meaning we can develop tests, faster and more cost effectively, allowing us to get them into the hands of people who need them sooner!

https://www.aptamergroup.co.uk/covid-19-reagents/

At, Aptamer Group Ltd, our scientists are continuously working to develop an aptamer binder selective for the spike protein in SARS CoV-2 which we expect to complete in 3-4 weeks. Our aim is to work this into a point-of-use test for the detection of virus itself, and have a proof-of-concept in two months. Please contact us using the form below if you would like more information and if this is something that you’d like to get involved in.

https://www.aptamergroup.co.uk/applications-of-aptamers-in-detection-and-therapeutics-of-sars-cov/

all delayed buys?

Interview still happening. Hopefully RNS this week.

Sorry crux is another stock. My mistake.

Or am I getting it mixed up?

Stockbox has been ousted back. Crux has already happened per twitter and should be released this week.

There is an interview tomorrow. Confirmed an hour ago.

It appears as though they didn't let this go yesterday but quick to mark down today?

Low mcap and great potential.

Current mcap only £5m.

The 37k looks like a UT trade!

Daisydog its says 31 percent of total Bushveld attributable vandium production.

74% of Vanetco production is 482.50 plus 219 = 701.50. 219/701.50=31.2%

Pdub - it is also worth pointing out that due to the weaker ZAR:USD rate the ZAR 375m facility when converted to dollars is $5m lower than when agreed? A gain to BMN!

The benefits and importance of having stock on hand. Despite the shut down sales were still being made.

Paul your summary beat me to it.

Q4 2019 vandaium sold 673. Q3 2019 604.

Q1 2020 898. Despite the shut down more vandaium sold. In addition sales from Vanchem achieved too.

Early maintenance completed.

Production costs down.

Production back up and running.

Cash at bank positive.

Overall a solid update.

I didn't say that!

Knutsford who's an idiot?